| Application no. and date | 17719107.9 (espacenet) (Federated) (European Patent Register), 20170407 | | Patent/reg. no. and date | DK/EP 3439689, 20211013 | | Publication date | 20190213 | | Priority no. and date | US 201662319980 P, 20160408, US 201762453110 P, 20170201 | | EP pub. no. and date |
EP 3439689 20190213 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V351343DK00 | | Inventor | MURPHY, Andrew J., c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
GROMADA, Jesper, c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
GUSAROVA, Viktoria, c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 3/06 (2006.01) , C07K 16/22 (2006.01) | | Title | Fremgangsmåder til behandling af hyperlipidæmi med en ANGPTL8-hæmmer og en ANGPTL3-hæmmer | | Int. application no. | US2017026679 | | Int. publication no. | WO2017177181 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
